Industry reports
Editor highlights

Therapy Companies, April 2014

You might be interested in: therapeutics, rnai therapeutics, immunotherapy, more »

» Read our Company Profiles

About 100 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

Eli Lilly and Co.

United States

AstraZeneca PLC

United Kingdom

Biogen Idec

United States

Lilly and Co.

United States

Amgen Inc.

United States

Abbott Laboratories

United States

Bristol-Myers Squibb Co.

United States

Bayer AG

Germany

Merck KGaA

Germany

Celgene Corp.

United States

Allergan Inc.

United States

Genzyme Corp.

United States

Biogen Idec Inc.

United States

Nektar Therapeutics

United States

Genentech Inc.

United States

Cephalon Inc.

United States

Teva Pharmaceuticals

United States

» View Public Reports

About 700 reports

Vaccination Market in Egypt

  • Industry report
  • December 2013
  • 27 pages

... vaccination delivered through campaigns Production system prod. Cycle length (days) eligible days for 1 shot (days) flock coverage with 2 shots (%) duration after 2 shots to achieve 100 ...


» Purchase Premium Reports (From $ 55 - $ 5 995)

About 5 900 reports
OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update

  • $ 5 995
  • Industry report
  • March 2014
  • by Global Data

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update Summary GlobalData has released its new Opportunity Analyzer report, “Oppo ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.